Apollo Endosurgery, Inc. (APEN) financial statements (2020 and earlier)

Company profile

Business Address 1120 SOUTH CAPITAL OF TX HWY
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3524311991712
Cash and cash equivalents3524311991712
Receivables9111211011
Inventory, net of allowances, customer advances and progress billings11101412  
Inventory11101412   
Other undisclosed current assets3312000
Total current assets:5848584491813
Noncurrent Assets
Property, plant and equipment7677000
Intangible assets, net (including goodwill)14154350222
Goodwill5577   
Intangible assets, net (excluding goodwill)8103643222
Restricted cash and investments1111   
Other noncurrent assets5401000
Total noncurrent assets:26265159232
TOTAL ASSETS:8474109102122116
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20242612143
Accounts payable1015185032
Accrued liabilities10987000
Employee-related liabilities    111
Due to related parties   9   
Deferred revenue and credits  001
Total current liabilities:20242620144
Noncurrent Liabilities
Long-term debt and lease obligation53213339   
Long-term debt, excluding current maturities53213339   
Liabilities, other than long-term debt1    00
Deferred revenue and credits   00
Other undisclosed liabilities, other than long-term debt1      
Other undisclosed noncurrent liabilities     12
Total noncurrent liabilities:54213339 12
Total liabilities:74465960156
Stockholders' equity
Stockholders' equity attributable to parent, including:10295042111610
Common stock0000000
Additional paid in capital250249225191878259
Accumulated other comprehensive income3321   
Accumulated deficit(243)(223)(177)(150)(76)(66)(49)
Warrants and rights outstanding     12
Other undisclosed stockholders' equity attributable to parent     (1)(2)
Total stockholders' equity:10295042111610
TOTAL LIABILITIES AND EQUITY:8474109102122116

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues54616465258
Cost of revenue(27)(28)(25)(25)   
Cost of goods and services sold(19)(0)(1)(4)   
Gross profit:27334040258
Operating expenses(60)(73)(62)(60)(12)(23)(16)
Operating loss:(33)(40)(22)(21)(11)(18)(8)
Nonoperating income (expense)(1)(1)(0)(2)011
Other nonoperating income (expense)(1)(1)(0)(2)000
Interest and debt expense(4)(4)(5)(18)   
Loss from continuing operations before income taxes:(38)(46)(27)(41)(11)(17)(7)
Income tax expense(0)(0)(0)(0)   
Net loss attributable to parent:(39)(46)(27)(41)(11)(17)(7)
Other undisclosed net income available to common stockholders, basic    1  
Net loss available to common stockholders, diluted:(39)(46)(27)(41)(10)(17)(7)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(39)(46)(27)(41)(11)(17)(7)
Comprehensive loss:(39)(46)(27)(41)(11)(17)(7)
Other undisclosed comprehensive income, net of tax, attributable to parent0101   
Comprehensive loss, net of tax, attributable to parent:(38)(45)(27)(40)(11)(17)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: